ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution
ZBHPartner Reed Kathrein Scrutinizing ZBH's "High Confidence" Assurances After 15% Stock Collapse and Reduced Revenue Guidance SAN FRANCISCO, Feb. 4, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is investigating Zimmer Biomet Holdings, Inc. (NYSE: ZBH) following a...
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution
ZBHPartner Reed Kathrein Scrutinizing ZBH's "High Confidence" Assurances After 15% Stock Collapse and Reduced Revenue Guidance SAN FRANCISCO, Jan. 27, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is investigating Zimmer Biomet Holdings, Inc. (NYSE: ZBH) following a...
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results
ZBHWARSAW, Ind., Jan. 15, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its fourth quarter earnings conference call will be webcast on Tuesday, February 10, 2026, at 8:30 a.m. ET. A news release detailing the...
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2025
ZBHWARSAW, Ind., Dec. 17, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2025. The cash...
Zimmer Biomet, OneStep Collaborate to Provide Enhanced Mobility Data to Patients and Surgeons to Help Improve Joint Procedure Recovery
ZBHOneStep's Clinically Validated Mobility Intelligence Technology to Integrate into Zimmer Biomet's mymobility® Care Management Platform to Further Enhance Recovery Monitoring WARSAW, Ind., Dec. 16, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical...
Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation, Reduced Top-Line Revenue Forecast -- Hagens Berman
ZBHSAN FRANCISCO, Nov. 18, 2025 /PRNewswire/ -- On November 5, 2025, investors in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) saw the price of their shares tumble $15.63 (-15%) after the company announced its Q3 2025 financial results and revealed cancelation of emerging markets distributor...
Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference
ZBH(NYSE:ZBH) WARSAW, Ind., Sept. 4, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its participation in the American Orthopedic Foot and Ankle Society Annual Conference in Savannah, Ga. From September 10-13, 2025, Zimmer...
Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care
ZBHDr. Jonathan M. Vigdorchik Named Chief Medical Technology Advisor, Adult Reconstruction and Hip Implants Dr. Anand M. Murthi Appointed Chief Medical Advisor, Shoulder, Sports, Extremities, and Trauma (S.E.T.) WARSAW, Ind., Aug. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE...
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025
ZBHWARSAW, Ind., Aug. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2025. The cash...
Zimmer Biomet to Present at the Annual Morgan Stanley Healthcare Conference
ZBHWARSAW, Ind., Aug. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the Annual Morgan Stanley Healthcare Conference on Monday, September 8, 2025, at 8:30 a.m. ET. A live...
Zimmer Biomet Announces Second Quarter 2025 Financial Results
ZBHSecond quarter net sales of $2.077 billion increased 7.0% on a reported basis, 5.4% on a constant currency1 basis and 2.8% on an organic constant currency1 basis Second quarter diluted earnings per share were $0.77; adjusted1 diluted earnings per share were $2.07, an increase of 3.0%...
Zimmer Biomet Appoints Kevin Thornal As Group President, Global Businesses And Americas, Effective July 1, 2025
ZBHAssessing Zimmer Biomet Holdings: Insights From 10 Financial Analysts
ZBHCanaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Lowers Price Target to $101
ZBHJMP Securities Maintains Market Outperform on Zimmer Biomet Holdings, Lowers Price Target to $125
ZBHThese Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results
ZBHGoldman Sachs Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $104
ZBHRaymond James Maintains Outperform on Zimmer Biomet Holdings, Lowers Price Target to $104
ZBHStifel Maintains Buy on Zimmer Biomet Holdings, Lowers Price Target to $115
ZBHRBC Capital Maintains Outperform on Zimmer Biomet Holdings, Lowers Price Target to $112
ZBHMorgan Stanley Maintains Equal-Weight on Zimmer Biomet Holdings, Lowers Price Target to $95
ZBHHow Is The Market Feeling About Zimmer Biomet Holdings?
ZBHJP Morgan Maintains Overweight on Zimmer Biomet Holdings, Lowers Price Target to $105
ZBHWells Fargo Maintains Equal-Weight on Zimmer Biomet Holdings, Lowers Price Target to $98
ZBHBaird Maintains Outperform on Zimmer Biomet Holdings, Lowers Price Target to $115
ZBHHip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal
ZBHZimmer Biomet Q1 sales rose 1.1% to $1.91 billion; FY25 EPS outlook trimmed but revenue growth forecast lifted following Paragon 28 acquisition.
Zimmer Biomet Holdings Lowers FY2025 Adj EPS Guidance from $8.15-$8.35 to $7.90-$8.10 vs $8.19 Est; Revenue for 2025 FY is expected to up by 5.7% - 8.2% YoY
ZBHZimmer Biomet Holdings Q1 Adj. EPS $1.81 Beats $1.77 Estimate, Sales $1.91B Beat $1.90B Estimate
ZBHA Glimpse of Zimmer Biomet Holdings's Earnings Potential
ZBHIs the Market Bullish or Bearish on Zimmer Biomet Holdings?
ZBHPrice Over Earnings Overview: Zimmer Biomet Holdings
ZBHLooking Into Zimmer Biomet Holdings's Recent Short Interest
ZBHZimmer Biomet Receives FDA Clearance For Persona Revision SoluTion Femur, Offering Alternative For Patients With Metal Sensitivities
ZBHIs the Market Bullish or Bearish on Zimmer Biomet Holdings?
ZBHZimmer Biomet Receives CE Mark Certification For The Persona Revision Knee System
ZBHWhat 21 Analyst Ratings Have To Say About Zimmer Biomet Holdings
ZBHRBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $125
ZBHTruist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $117
ZBHWells Fargo Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $117
ZBH(ZBH) - Analyzing Zimmer Biomet Holdings's Short Interest
ZBHNeedham Reiterates Hold on Zimmer Biomet Holdings
ZBHOrthopedic Implants Maker Zimmer Biomet Gains Analyst Upgrade Amid Promising Growth From New Products, Demographic Trends
ZBHZimmer Biomet receives an upgrade from Argus Research due to new product launches and strategic acquisitions.
In-Depth Examination Of 6 Analyst Recommendations For Zimmer Biomet Holdings
ZBHArgus Research Upgrades Zimmer Biomet Holdings to Buy, Announces $150 Price Target
ZBHNeedham Reiterates Hold on Zimmer Biomet Holdings
ZBHSVB Leerink Maintains Outperform Rating for Zimmer Biomet Holdings: Here's What You Need To Know
ZBHSVB Leerink has decided to maintain its Outperform rating of Zimmer Biomet Holdings (NYSE:ZBH) and raise its price target from $135.00 to $140.00.
Shares of Zimmer Biomet Holdings are trading up 0.82% over the last 24 hours, at $121.67 per share.
Analyst Ratings for Zimmer Biomet Holdings
ZBHWithin the last quarter, Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings:
RBC Capital Maintains Sector Perform on Zimmer Biomet Holdings, Raises Price Target to $128
ZBHSVB Leerink Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $140
ZBHZimmer Biomet Raises, Tightens FY22 Outlook after Q1 Earnings Surpass Estimates
ZBH